Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹0.60Accepted-AOC | ₹0.60 | L1 | Accepted-AOC L1 |
| 2 | L1₹0.60Accepted-AOC | ₹0.60 | L1 | Accepted-AOC L1 |
| 3 | L2₹1.25+₹0.65 (108.3%)Rejected-Finance | ₹1.25+₹0.65 (108.3%) | L2 | Rejected-Finance L2 |
| 4 | L3₹1.52+₹0.92 (153.3%)Rejected-Finance | ₹1.52+₹0.92 (153.3%) | L3 | Rejected-Finance L3 |
| Sl No | Description | Qty | Unit | SANOFI INDIA LIMITED L3 | M J Biopharm Pvt. Ltd. L2 | WOCKHARDT LTD L1 | Biocon Biologics Limited L1 |
|---|---|---|---|---|---|---|---|
| 1.00 | Bupropion hydrochloride 150mg Tab. | 15,000 | Strip of 10 Tabs | - | - | - | - |
| 2.00 | Carboplatin Inj. 450 mg./ Vial | 20,000 | Vial | - | - | - | - |
| 3.00 | Haloperidol Tab. 0.25mg | 7,000 | Strip of 10 Tabs | - | - | - | - |
| 4.00 | Insulin (Human pre mixed ) Soluble & NPH combination (30 : 70) or (25:75)/ I.U. -in Vial(Maximum pack size allowed 10ml /vial) | 16,00,00,000 | Per IU | - | - | - | - |
| 5.00 | Insulin Glargine (rDNA 100 I.U./ml) -in Vial / PFS/Cartridge | 4,00,00,000 | Per IU | 1.52 ₹1.52 | 1.25 ₹1.25 | 0.6 ₹0.6 Lowest | 0.6 ₹0.6 Lowest |
| 6.00 | Insulin Soluble Inj. I.P.40 I.U. / ml in 10 ml Vial . | 5,000 | Box of 20 Vials | - | - | - | - |
| 7.00 | Nortriptyline 25mg Tab. | 15,000 | Strip of 10 Tabs | - | - | - | - |
| 8.00 | Zinc Sulphate 20 mg. (Dispersable) Tab. | 50,00,000 | Strip of 10 Tabs | - | - | - | - |
| 200.00Important Note: 1. All prospective bidders are requested to quote the rate in BOQ as per Accounting Unit & item specification as mentioned in the Table-A. Wrong Quoting of the rate in BOQ will be dealt with as per penal provisions of the T&C of the Tender. 2. Tendered quantity is just a tentative quantity and should not be treated as final. It may increase or decrease, as per need of the state. Keeping this in mind, the supplier is not allowed to seek termination of the Rate Contract after finishing supply of tendered quantity. 3. Quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 4. The prospective Bidders of the said Tender are requested to make a declaration in Affidavit under Annexure VI(b) in case of sole manufacturer/importer (i.e. proprietary in nature). 5. If the Item(s) under sole manufacturer / importer is (are) Proprietary in nature, quarterly intimation is solicited from the approved Bidders positively regarding the status of their Item(s) Proprietary in nature, otherwise their Item(s) will be blocked in the SMIS. 6. In case of Tie Bid, decision will be taken by the TIA as per G.O. No. 2320-F(Y), dated 07.06.2022 issued from Finance Department Audit Branch (Group T). | |||||||
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
16 Mar 2026, 11:00 amClosed
Dy. Director of Health Services (E andS)
Central Medical Stores 141, A J C Bose Road, Kolkata 700014
E-TENDER FOR PROCUREMENT OF DRUG ITEMS UNDER TABLE-A, FOR TWO YEARS FROM THE DATE OF AOC
2026_HFW_1010660_1
WBHF/CMS/HST/4T-124-2026 /DI/2026/380
Open Tender
Medicines
Item Wise
730 days
KOLKATA
Please refer Tender documents.
3 documents required · 3 mandatory
₹2 L
Yes
21 Aug 2026
19 Feb 2026
16 Mar 2026
19 Feb 2026
16 Mar 2026
27 Feb 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Bupropion hydrochloride 150mg Tab. | 15,000 | Strip of 10 Tabs | - | - |
| 2 | Carboplatin Inj. 450 mg./ Vial | 20,000 | Vial | - | - |
| 3 | Haloperidol Tab. 0.25mg | 7,000 | Strip of 10 Tabs | - | - |
| 4 | Insulin (Human pre mixed ) Soluble & NPH combination (30 : 70) or (25:75)/ I.U. -in Vial(Maximum pack size allowed 10ml /vial) | 16,00,00,000 | Per IU | - | - |
| 5 | Insulin Glargine (rDNA 100 I.U./ml) -in Vial / PFS/Cartridge | 4,00,00,000 | Per IU | - | - |
| 6 | Insulin Soluble Inj. I.P.40 I.U. / ml in 10 ml Vial . | 5,000 | Box of 20 Vials | - | - |
| 7 | Nortriptyline 25mg Tab. | 15,000 | Strip of 10 Tabs | - | - |
| 8 | Zinc Sulphate 20 mg. (Dispersable) Tab. | 50,00,000 | Strip of 10 Tabs | - | - |
| 200 | Important Note:
1. All prospective bidders are requested to quote the rate in BOQ as per Accounting Unit & item specification as mentioned in the Table-A. Wrong Quoting of the rate in BOQ will be dealt with as per penal provisions of the T&C of the Tender.
2. Tendered quantity is just a tentative quantity and should not be treated as final. It may increase or decrease, as per need of the state. Keeping this in mind, the supplier is not allowed to seek termination of the Rate Contract after finishing supply of tendered quantity.
3. Quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.
4. The prospective Bidders of the said Tender are requested to make a declaration in Affidavit under Annexure VI(b) in case of sole manufacturer/importer (i.e. proprietary in nature).
5. If the Item(s) under sole manufacturer / importer is (are) Proprietary in nature, quarterly intimation is solicited from the approved Bidders positively regarding the status of their Item(s) Proprietary in nature, otherwise their Item(s) will be blocked in the SMIS.
6. In case of Tie Bid, decision will be taken by the TIA as per G.O. No. 2320-F(Y), dated 07.06.2022 issued from Finance Department Audit Branch (Group T). | - | - | - | - |
stage.html
html • 0.05 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 1.84 MB
Technical_Data_Sheet_380.xls
Tender Documents • 2.74 MB
BOQ_2481460.xls
BOQ • 0.32 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .